George Agriantonis

Elmhurst Hospital Center

Papers

1

Total Citations

2

H-Index

1

About

George Agriantonis is a rising clinical researcher whose work centers on gastrointestinal oncology, with a particular focus on gastric adenocarcinoma. His most-cited study, "Trends in Clinicopathologic and Treatment Outcomes in Patients with Gastric Adenocarcinoma in the United States Between 2004 and 2021," published in 2025, has already garnered 2 citations, signaling early impact in the field. This work provides a comprehensive, population-level analysis of evolving disease patterns, patient demographics, and therapeutic approaches over nearly two decades, offering critical insights into disparities and shifting outcomes in gastric cancer care. Agriantonis’s research is distinguished by its use of large-scale national datasets to uncover real-world trends, bridging gaps between clinical trials and everyday practice. His contributions are particularly valuable for oncologists and public health researchers seeking to understand how treatment paradigms have changed and where improvements are still needed. As an emerging voice in surgical and medical oncology, Agriantonis demonstrates a commitment to evidence-based, data-driven analysis that can inform future guidelines and resource allocation. With his work already drawing attention, he is poised to become a key contributor to the fight against gastrointestinal malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Trends in Clinicopathologic and Treatment Outcomes in Patients with Gastric Adenocarcinoma in the United States Between 2004 and 2021
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Elmhurst Hospital Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago